Tag Archives: LLY

5 Things AbbVie Investors Need to Know

Has the luster faded for AbbVie (NYSE:ABBV)?

The big pharma company ranked as the best performer among its peers in 2017, with an impressive gain of 54%. AbbVie started off 2018 great as well. However, disappointing results from a phase 2 clinical study of cancer drug Rova-T caused the stock to skid.

Still, AbbVie’s top executives remain very optimistic about the company’s....More>>>

Ziopharm’s Pause On Its Phase 3 Brain Cancer Study Is More Valuable Than You Think

Recently, Ziopharm Oncology (NASDAQ:ZIOP) gave an update on its first-quarter 2018 earnings report. It noted that a phase 3 study would be paused for the time being. The biotech is now pointing to its other mid-stage studies as being more prominent than the phase 3 study that was supposed to start soon treating patients with recurrent glioblastoma (brain cancer). I have to agree with this assessment,....More>>>

Ziopharm’s Pause On Its Phase 3 Brain Cancer Study Is More Valuable Than You Think

Recently, Ziopharm Oncology (NASDAQ:ZIOP) gave an update on its first-quarter 2018 earnings report. It noted that a phase 3 study would be paused for the time being. The biotech is now pointing to its other mid-stage studies as being more prominent than the phase 3 study that was supposed to start soon treating patients with recurrent glioblastoma (brain cancer). I have to agree with this assessment,....More>>>

Week In Review: $3.4 Billion Week For China Life Science Deals

Armo BioSciences (NASDAQ:ARMO), a Bay Area immuno-oncology company, agreed to be acquired by Eli Lilly (NYSE:LLY) in a $1.6 billion transaction. Last year, Armo raised $67 million in a 2017 Series C-1 funding from China investors. Four months ago, Armo completed a $128 million IPO at a $500 million valuation. Lilly offered to pay $50 per share for Armo, a three-fold increase from the IPO price and....More>>>

Top 10 Undervalued Stocks To Watch Right Now

If youre looking for an undervalued company in the auto segment thats almost guaranteed to grow slow and steady over the long term, then the Lear Corporation (LEA) should definitely be on your vetting list. The lowly PE ratio of 10 is merely the bitter aftertaste of investors in a company that went belly up during the great recession because of its debt pile. I believe the company has shaken off....More>>>

what is stock

Bull markets become trickiest to navigate just when they start to look easy. Lately, this one has been a breeze. Investors in U.S. stocks have gotten more than a years worth of gains in six months, with Standard & Poors 500-stock index returning 12.5% since last Novembers election, far ahead of the long-term annual average of 10%.

SEE ALSO: 5 Stocks to Buy Now

Moreover,....More>>>

best stock news

New Yorkers should avoid the area surrounding Trump Tower, Mayor Bill de Blasio said on Friday — not exactly the type of advice area businesses want to hear heading into the holiday season.

Donald Trump’s neighborhood in Midtown Manhattan has been flooded by cops, Secret Service agents and protesters along with the usual hordes of shoppers, tourists and office workers since his....More>>>

things to invest in now

What a difference one word makes. Cowen’s Doug Creutz and Stephen Glagola could have said that it’s not time to panic after Viacom (VIAB) said its negotiations with Dish Network (DISH) have been going nowhere. Instead, they inserted the word “necessarily,” changing the complexion of things. They explain:

Bloomberg News

Viacom shares are down several percent....More>>>

Best Casino Stocks To Buy For 2018

Related MPEL Macau Records Largest Monthly Revenue Growth In Nearly 3 Years Is Monthly Gaming Win Data Still A Viable Trading Opportunity? Macau posts best monthly revenue growth since early 2014 (Seeking Alpha) Related WYNN Macau Records Largest Monthly Revenue Growth In Nearly 3 Years Is Monthly....More>>>

Top 5 Performing Stocks To Buy For 2017

One of last week’s biggest winners wasGroupon (NASDAQ:GRPN), soaring 30.2% after posting strong quarterly results.Revenue clocked in at $934.9 million for the fourth quarter, up a mere 1.9% for the top dog in daily deals.

Checking in with less than 2% in top-line growth may not seem very impressive, but it’s all relative. Groupon’s been retreating out of poorly performing....More>>>